|
Evaxion A/S
(NASDAQ: EVAX)
|
9:00 PM UTC, 12/12/25 | |||
|---|---|---|---|---|
| Last: $6.21 | Change: -0.24 | %Change: -3.72% | Volume: 70,895 | |
11:07 AM EST, 03/04/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts fell late Tuesday morning with the S&P Europe Select ADR Index down 0.75% to 1,409.96
From continental Europe, the gainers were led by consumer goods giant Unilever (UL) and pharmaceutical company Sanofi (SNY), which rose 2.3% and 1.9% respectively. They were followed by brewing company Anheuser-Busch InBev (BUD) and medical device maker EDAP TMS (EDAP), which were up 1.4% and 0.4% respectively.
The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and semiconductor company Sequans Communications (SQNS), which lost 5.6% and 4.9% respectively. They were followed by financial services company Banco Santander (SAN) and biopharmaceutical company DBV Technologies (DBVT), which dropped 4.4% and 4.3% respectively.
From the UK and Ireland, the gainers were led by pharmaceutical companies Silence Therapeutics (SLN) and GSK (GSK), which increased 3% and 2.9% respectively. They were followed by educational publisher Pearson (PSO) and biotech company Autolus Therapeutics (AUTL), which advanced 2.5% and 1.7% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company TC Biopharm (TCBP) and construction materials supplier CRH (CRH), which fell 9.6% and 6.4% respectively. They were followed by cruise line operator Carnival (CUK) and biopharmaceutical company NuCana (NCNA), which were down 5.9% and 3.1% respectively.
http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.